Related Experiment Video
Updated: Apr 17, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses
Anne Lenaerts1, Clifton E Barry, Véronique Dartois
1Department of Microbiology, Immunology and Pathology, Colorado State University, Ft. Collins, CO, USA.
Tuberculosis lesions are complex and varied, impacting Mycobacterium tuberculosis adaptation and treatment response. Understanding this heterogeneity is key for developing new tuberculosis therapies and biomarkers.
Area of Science:
- Immunology
- Microbiology
- Pulmonary Medicine
Background:
- Tuberculosis (TB) lesions are complex and dynamic pulmonary sites.
- Mycobacterium tuberculosis (M.tb) infection leads to diverse granulomas and cavities.
- These structures create varied microenvironments influencing bacterial populations.
Purpose of the Study:
- To review the types and fates of pulmonary TB lesions.
- To examine the impact of lesion heterogeneity on M.tb.
- To discuss recent paradigm shifts in understanding lesion progression.
Main Methods:
- Literature review of TB lesion dynamics.
- Analysis of host-pathogen interactions within lesions.
- Synthesis of current research on lesion heterogeneity.
Main Results:
- TB lesions exhibit spatial and temporal heterogeneity.
- Microenvironments within lesions affect M.tb replication, metabolism, and density.
- Bacterial subpopulations show differential susceptibility to chemotherapy.
- Lesion progression is dynamic and locally driven, not uniform.
Conclusions:
- A paradigm shift is occurring in understanding TB lesion progression.
- Lesion heterogeneity impacts treatment efficacy and necessitates personalized approaches.
- Further research is needed for predictive biomarkers and novel therapies.
Related Concept Videos
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...

